Metraipolis › archive › dc_fbad6d503595
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase,… — Europe PMC PMID:41438985
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41438985
- DOI
- 10.3389/fonc.2025.1704021
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:50:28.601Z
- SHA-256 of the archived text
f8c68f28d466ed6b65c0b09fc5a48543e8512aabf9b0b4736dce6f53a1d49b83- Stable URL of this page
https://metraipolis.com/documento/dc_fbad6d503595
How to cite
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase,… — Europe PMC PMID:41438985 — Europe PMC (en), https://europepmc.org/article/MED/41438985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbad6d503595 (Metraipolis archive dc_fbad6d503595, sha256 f8c68f28d466ed6b65c0b09fc5a48543e8512aabf9b0b4736dce6f53a1d49b83)
BibTeX
@misc{dcfbad6d503595,
title = {Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase,… — Europe PMC PMID:41438985},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41438985},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbad6d503595; sha256 f8c68f28d466ed6b65c0b09fc5a48543e8512aabf9b0b4736dce6f53a1d49b83},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41438985. Agents can read the archived copy with the MCP tool read_document.